Review article · 2017 · Open access
Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis
Frontiers in Pharmacology, 8, 243 · Published 5 May 2017 · DOI 10.3389/fphar.2017.00243
In brief
“Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis” is a 2017 review article by Elizabeth A. Vecchio and 2 co-authors, published in Frontiers in Pharmacology. OpenAlex counts 60 citations as of 21 November 2026, which puts it in the top 6% of works published in 2017 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Pharmacology.
- Citations
- 60
- Most cited in
- 2018 (11)
- Field-weighted impact
- 0.82
- References
- 79
- Authors
- 3
Abstract
Adenosine is a ubiquitous molecule with key regulatory and cytoprotective mechanisms at times of metabolic imbalance in the body. Among a plethora of physiological actions, adenosine has an important role in attenuating ischaemia-reperfusion injury and modulating the ensuing fibrosis and tissue remodelling following myocardial damage. Adenosine exerts these actions through interaction with four adenosine G protein-coupled receptors expressed in the heart. The adenosine A2B receptor (A2BAR) is the most abundant adenosine receptor in cardiac fibroblasts and is largely responsible for the influence of adenosine on cardiac fibrosis. In vitro and in vivo studies demonstrate that acute A2BAR stimulation can decrease fibrosis through the inhibition of fibroblast proliferation and reduction in collagen synthesis. However, in contrast, there is also evidence that chronic A2BAR antagonism reduces tissue fibrosis. This review explores the opposing pro- and anti-fibrotic activity attributed to the activation of cardiac adenosine receptors and investigates the therapeutic potential of targeting adenosine receptors for the treatment of cardiac fibrosis.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Vecchio, E. A., White, P. J., & May, L. T. (2017). Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis. Frontiers in Pharmacology, 8, 243. https://doi.org/10.3389/fphar.2017.00243
MLA 9
Vecchio, Elizabeth A., et al. “Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis.” Frontiers in Pharmacology, vol. 8, 2017, p. 243. https://doi.org/10.3389/fphar.2017.00243.
Chicago
Vecchio, Elizabeth A., Paul James White, and Lauren Therese May. 2017. “Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis.” Frontiers in Pharmacology 8: 243. https://doi.org/10.3389/fphar.2017.00243.
Harvard
Vecchio, E. A., White, P. J. and May, L. T. (2017) ‘Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis’, Frontiers in Pharmacology, 8, p. 243. doi:10.3389/fphar.2017.00243.
IEEE
E. A. Vecchio, P. J. White, and L. T. May, “Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis,” Frontiers in Pharmacology, vol. 8, p. 243, 2017, doi: 10.3389/fphar.2017.00243.
BibTeX
@article{vecchio2017targeting,
title = {{Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis}},
author = {Vecchio, Elizabeth A. and White, Paul James and May, Lauren Therese},
journal = {Frontiers in Pharmacology},
year = {2017},
volume = {8},
pages = {243},
doi = {10.3389/fphar.2017.00243},
url = {https://doi.org/10.3389/fphar.2017.00243}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 4 | |
| 2018 | 11 | |
| 2019 | 9 | |
| 2020 | 7 | |
| 2021 | 7 | |
| 2022 | 3 | |
| 2023 | 7 | |
| 2024 | 4 | |
| 2025 | 4 | |
| 2026 | 4 |
Its field-weighted citation impact is 0.82: it has been cited 0.82 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- adenosine receptors
- myocardial fibrosis
- adenosine A2B receptor
- G protein-coupled receptors
- cardiac fibroblasts
- ischemia-reperfusion injury
- fibroblast proliferation
- collagen synthesis
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Vecchio, E. A., White, P. J., & May, L. T. (2017). Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis. Frontiers in Pharmacology, 8, 243. https://doi.org/10.3389/fphar.2017.00243
How many times has this paper been cited?
60 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Pharmacology: sign in and open the PDF from this page.
Who wrote this paper?
Elizabeth A. Vecchio, Paul James White, Lauren Therese May.
What is the DOI of this paper?
10.3389/fphar.2017.00243, permanently at https://doi.org/10.3389/fphar.2017.00243. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.